CAPLIN POINT LABORATORIES
Back to Balance Sheet
|
CAPLIN POINT LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-13 Cr | ₹-14 Cr | ₹-6.21 Cr | ₹1.16 Cr | ₹10 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of CAPLIN POINT LABORATORIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-13 Cr |
Mar2023 | ₹-14 Cr |
Mar2022 | ₹-6.21 Cr |
Mar2021 | ₹1.16 Cr |
Mar2020 | ₹10 Cr |
How is Deferred Tax Assets / Liabilities of CAPLIN POINT LABORATORIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-13 Cr | Negative | |
Mar2023 | ₹-14 Cr | Negative | |
Mar2022 | ₹-6.21 Cr | Negative | |
Mar2021 | ₹1.16 Cr | -88.53 | |
Mar2020 | ₹10 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of CAPLIN POINT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CAPLIN POINT LABORATORIES | ₹15,030.5 Cr | -0.5% | 8.5% | 50.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹411,306.0 Cr | -2.5% | 7.6% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹150,343.0 Cr | -3% | 3.4% | 61.5% | Stock Analytics | |
CIPLA | ₹117,323.0 Cr | -1.6% | 3% | -3.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,619.0 Cr | -0.3% | 9% | 22.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,941.5 Cr | -1.2% | 2.9% | -6.4% | Stock Analytics |
CAPLIN POINT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CAPLIN POINT LABORATORIES | -0.5% |
8.5% |
50.2% |
SENSEX | -1.8% |
2.7% |
5% |
You may also like the below Video Courses